Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 21, 2022

SELL
$9.95 - $12.27 $636 - $785
-64 Reduced 10.08%
571 $6,000
Q1 2022

May 05, 2022

SELL
$9.81 - $15.4 $382 - $600
-39 Reduced 5.79%
635 $7,000
Q4 2021

Feb 09, 2022

SELL
$12.09 - $14.68 $1,656 - $2,011
-137 Reduced 16.89%
674 $9,000
Q3 2021

Nov 08, 2021

SELL
$13.25 - $15.13 $2,014 - $2,299
-152 Reduced 15.78%
811 $11,000
Q2 2021

Jul 29, 2021

BUY
$12.97 - $16.15 $2,516 - $3,133
194 Added 25.23%
963 $14,000
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $312 - $426
-23 Reduced 2.9%
769 $11,000
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $11,325 - $14,842
792 New
792 $15,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Charter Oak Capital Management, LLC Portfolio

Follow Charter Oak Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charter Oak Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Charter Oak Capital Management, LLC with notifications on news.